nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—DRD4—conduct disorder	0.888	1	CbGaD
L-DOPA—DRD5—Dopamine receptors—DRD4—conduct disorder	0.00891	0.0842	CbGpPWpGaD
L-DOPA—DDC—Amine-derived hormones—CGA—conduct disorder	0.00799	0.0754	CbGpPWpGaD
L-DOPA—DRD1—Dopamine receptors—DRD4—conduct disorder	0.00592	0.0559	CbGpPWpGaD
L-DOPA—DRD3—Dopamine receptors—DRD4—conduct disorder	0.00584	0.0552	CbGpPWpGaD
L-DOPA—DRD2—Dopamine receptors—DRD4—conduct disorder	0.00447	0.0422	CbGpPWpGaD
L-DOPA—DDC—Dopamine metabolism—COMT—conduct disorder	0.00426	0.0402	CbGpPWpGaD
L-DOPA—DDC—Dopamine metabolism—MAOA—conduct disorder	0.00423	0.0399	CbGpPWpGaD
L-DOPA—DDC—Biogenic Amine Synthesis—COMT—conduct disorder	0.0038	0.0358	CbGpPWpGaD
L-DOPA—DDC—Biogenic Amine Synthesis—MAOA—conduct disorder	0.00377	0.0356	CbGpPWpGaD
L-DOPA—DDC—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.0036	0.034	CbGpPWpGaD
L-DOPA—Methyldopa—COMT—conduct disorder	0.00245	0.402	CrCbGaD
L-DOPA—DRD5—Monoamine GPCRs—DRD4—conduct disorder	0.00197	0.0186	CbGpPWpGaD
L-DOPA—DRD3—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00185	0.0175	CbGpPWpGaD
L-DOPA—DRD5—Amine ligand-binding receptors—DRD4—conduct disorder	0.00166	0.0156	CbGpPWpGaD
L-DOPA—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00142	0.0134	CbGpPWpGaD
L-DOPA—DRD1—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00134	0.0127	CbGpPWpGaD
L-DOPA—DRD1—Monoamine GPCRs—DRD4—conduct disorder	0.00131	0.0124	CbGpPWpGaD
L-DOPA—DRD3—Monoamine GPCRs—DRD4—conduct disorder	0.00129	0.0122	CbGpPWpGaD
L-DOPA—DRD5—Monoamine GPCRs—HTR2A—conduct disorder	0.00129	0.0121	CbGpPWpGaD
L-DOPA—DRD5—G alpha (s) signalling events—CGA—conduct disorder	0.00122	0.0115	CbGpPWpGaD
L-DOPA—Dopamine—COMT—conduct disorder	0.00119	0.196	CrCbGaD
L-DOPA—DDC—Amino acid and derivative metabolism—CGA—conduct disorder	0.00111	0.0105	CbGpPWpGaD
L-DOPA—DRD1—Amine ligand-binding receptors—DRD4—conduct disorder	0.0011	0.0104	CbGpPWpGaD
L-DOPA—DRD3—Amine ligand-binding receptors—DRD4—conduct disorder	0.00109	0.0102	CbGpPWpGaD
L-DOPA—DRD5—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00108	0.0102	CbGpPWpGaD
L-DOPA—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00101	0.00956	CbGpPWpGaD
L-DOPA—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.000988	0.00933	CbGpPWpGaD
L-DOPA—Dopamine—DRD4—conduct disorder	0.000968	0.159	CrCbGaD
L-DOPA—DRD4—Monoamine GPCRs—HTR2A—conduct disorder	0.000949	0.00896	CbGpPWpGaD
L-DOPA—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000929	0.00877	CbGpPWpGaD
L-DOPA—Dopamine—MAOA—conduct disorder	0.0009	0.148	CrCbGaD
L-DOPA—DRD1—Monoamine GPCRs—HTR2A—conduct disorder	0.000854	0.00806	CbGpPWpGaD
L-DOPA—DRD3—Monoamine GPCRs—HTR2A—conduct disorder	0.000843	0.00796	CbGpPWpGaD
L-DOPA—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.000831	0.00784	CbGpPWpGaD
L-DOPA—DRD1—G alpha (s) signalling events—CGA—conduct disorder	0.000811	0.00765	CbGpPWpGaD
L-DOPA—DRD4—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000797	0.00753	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00077	0.00727	CbGpPWpGaD
L-DOPA—DRD1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000718	0.00678	CbGpPWpGaD
L-DOPA—DRD3—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000708	0.00669	CbGpPWpGaD
L-DOPA—SLC7A8—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000656	0.00619	CbGpPWpGaD
L-DOPA—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.000645	0.00609	CbGpPWpGaD
L-DOPA—DDC—Circadian rythm related genes—SLC6A4—conduct disorder	0.000628	0.00593	CbGpPWpGaD
L-DOPA—DDC—Circadian rythm related genes—DRD4—conduct disorder	0.000591	0.00558	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000582	0.00549	CbGpPWpGaD
L-DOPA—Dopamine—SLC6A4—conduct disorder	0.000581	0.0954	CrCbGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000579	0.00547	CbGpPWpGaD
L-DOPA—DRD3—GPCRs, Other—DRD4—conduct disorder	0.000574	0.00542	CbGpPWpGaD
L-DOPA—SLC7A5—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000572	0.0054	CbGpPWpGaD
L-DOPA—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000542	0.00512	CbGpPWpGaD
L-DOPA—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.000512	0.00483	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000472	0.00446	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—CGA—conduct disorder	0.000443	0.00418	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000429	0.00405	CbGpPWpGaD
L-DOPA—DRD4—GPCRs, Other—HTR2A—conduct disorder	0.000421	0.00398	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000386	0.00365	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000381	0.0036	CbGpPWpGaD
L-DOPA—SLC16A10—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00038	0.00359	CbGpPWpGaD
L-DOPA—DRD5—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00038	0.00359	CbGpPWpGaD
L-DOPA—DRD3—GPCRs, Other—HTR2A—conduct disorder	0.000374	0.00353	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—SLC6A4—conduct disorder	0.000364	0.00344	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—SLC6A4—conduct disorder	0.000328	0.0031	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—CGA—conduct disorder	0.000327	0.00309	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000326	0.00307	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—SLC6A4—conduct disorder	0.000324	0.00306	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—DRD4—conduct disorder	0.000308	0.00291	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—DRD4—conduct disorder	0.000304	0.00287	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000295	0.00279	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—CGA—conduct disorder	0.000294	0.00278	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000292	0.00275	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—CGA—conduct disorder	0.00029	0.00274	CbGpPWpGaD
L-DOPA—DRD3—G alpha (i) signalling events—DRD4—conduct disorder	0.000269	0.00254	CbGpPWpGaD
L-DOPA—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000253	0.00238	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—CGA—conduct disorder	0.00025	0.00236	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00025	0.00236	CbGpPWpGaD
L-DOPA—DRD3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000249	0.00235	CbGpPWpGaD
L-DOPA—DRD5—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000248	0.00234	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—DRD4—conduct disorder	0.000248	0.00234	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.000248	0.00234	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.000233	0.0022	CbGpPWpGaD
L-DOPA—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000232	0.00219	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CGA—conduct disorder	0.000227	0.00215	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CGA—conduct disorder	0.000222	0.0021	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000216	0.00204	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000214	0.00202	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000213	0.00201	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000205	0.00194	CbGpPWpGaD
L-DOPA—DDC—Metabolism—CGA—conduct disorder	0.000204	0.00193	CbGpPWpGaD
L-DOPA—DDC—Circadian rythm related genes—EP300—conduct disorder	0.000204	0.00193	CbGpPWpGaD
L-DOPA—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000191	0.0018	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CGA—conduct disorder	0.000185	0.00174	CbGpPWpGaD
L-DOPA—DRD4—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000183	0.00173	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CGA—conduct disorder	0.000168	0.00158	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CGA—conduct disorder	0.000166	0.00157	CbGpPWpGaD
L-DOPA—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000165	0.00156	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—DRD4—conduct disorder	0.000165	0.00156	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CGA—conduct disorder	0.000164	0.00155	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000163	0.00154	CbGpPWpGaD
L-DOPA—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000163	0.00154	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—DRD4—conduct disorder	0.000163	0.00154	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—HTR2A—conduct disorder	0.000162	0.00153	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000157	0.00148	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—EP300—conduct disorder	0.000156	0.00148	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CGA—conduct disorder	0.000151	0.00143	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CGA—conduct disorder	0.000149	0.00141	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000141	0.00133	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—DRD4—conduct disorder	0.00014	0.00132	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000139	0.00132	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—EP300—conduct disorder	0.000136	0.00129	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CGA—conduct disorder	0.000134	0.00127	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—DRD4—conduct disorder	0.000127	0.0012	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000126	0.00119	CbGpPWpGaD
L-DOPA—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000124	0.00117	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000124	0.00117	CbGpPWpGaD
L-DOPA—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000124	0.00117	CbGpPWpGaD
L-DOPA—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000123	0.00116	CbGpPWpGaD
L-DOPA—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000122	0.00115	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—HTR2A—conduct disorder	0.000119	0.00113	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—EP300—conduct disorder	0.000118	0.00112	CbGpPWpGaD
L-DOPA—PSIP1—Disease—EP300—conduct disorder	0.000116	0.0011	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000114	0.00108	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—WASF1—conduct disorder	0.000108	0.00102	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—HTR2A—conduct disorder	0.000108	0.00102	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—EP300—conduct disorder	0.000107	0.00101	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000107	0.00101	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—HTR2A—conduct disorder	0.000106	0.001	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—EP300—conduct disorder	0.000105	0.000993	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CGA—conduct disorder	9.91e-05	0.000936	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—DRD4—conduct disorder	9.31e-05	0.000879	CbGpPWpGaD
L-DOPA—DDC—Metabolism—COMT—conduct disorder	9.22e-05	0.000871	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—DRD4—conduct disorder	9.19e-05	0.000868	CbGpPWpGaD
L-DOPA—DDC—Metabolism—MAOA—conduct disorder	9.16e-05	0.000865	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—HTR2A—conduct disorder	9.14e-05	0.000863	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CGA—conduct disorder	8.92e-05	0.000842	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CGA—conduct disorder	8.8e-05	0.000831	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—DRD4—conduct disorder	8.46e-05	0.000798	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—DRD4—conduct disorder	8.34e-05	0.000788	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HTR2A—conduct disorder	8.3e-05	0.000784	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—HTR2A—conduct disorder	8.12e-05	0.000766	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—EP300—conduct disorder	8.05e-05	0.00076	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—WASF1—conduct disorder	7.94e-05	0.00075	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—DRD4—conduct disorder	7.52e-05	0.00071	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—WASF1—conduct disorder	7.15e-05	0.000675	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—WASF1—conduct disorder	7.05e-05	0.000666	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—DRD4—conduct disorder	7.03e-05	0.000664	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	6.75e-05	0.000637	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CGA—conduct disorder	6.74e-05	0.000636	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—DRD4—conduct disorder	6.38e-05	0.000603	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR2A—conduct disorder	6.13e-05	0.000579	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	6.08e-05	0.000574	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	6e-05	0.000566	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR2A—conduct disorder	5.52e-05	0.000521	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR2A—conduct disorder	5.44e-05	0.000514	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—WASF1—conduct disorder	5.4e-05	0.00051	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—DRD4—conduct disorder	5e-05	0.000472	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—DRD4—conduct disorder	4.93e-05	0.000465	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR2A—conduct disorder	4.91e-05	0.000463	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CGA—conduct disorder	4.7e-05	0.000444	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	4.59e-05	0.000433	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR2A—conduct disorder	4.17e-05	0.000393	CbGpPWpGaD
L-DOPA—DDC—Metabolism—EP300—conduct disorder	3.96e-05	0.000373	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—DRD4—conduct disorder	3.77e-05	0.000356	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR2A—conduct disorder	3.62e-05	0.000342	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR2A—conduct disorder	3.26e-05	0.000308	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR2A—conduct disorder	3.22e-05	0.000304	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—EP300—conduct disorder	2.6e-05	0.000245	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR2A—conduct disorder	2.46e-05	0.000232	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—COMT—conduct disorder	2.12e-05	0.0002	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MAOA—conduct disorder	2.11e-05	0.000199	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—EP300—conduct disorder	1.92e-05	0.000181	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—EP300—conduct disorder	1.73e-05	0.000163	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—EP300—conduct disorder	1.7e-05	0.000161	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EP300—conduct disorder	1.3e-05	0.000123	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—EP300—conduct disorder	9.1e-06	8.59e-05	CbGpPWpGaD
